4.5 Article

MDM2 is a useful prognostic biomarker for resectable gastric cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2012

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Article Oncology

Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer

Shouyu Wang et al.

CLINICAL CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

JWA enhances As2O3-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells

Lianlian Shen et al.

APOPTOSIS (2011)

Review Medicine, General & Internal

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

Xavier Paoletti et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Biochemistry & Molecular Biology

JWA regulates melanoma metastasis by integrin αVβ3 signaling

J. Bai et al.

ONCOGENE (2010)

Review Oncology

Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis

Bonnie E. Gould Rothberg et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Article Oncology

MDM2 SNP309 is associated with endometrial cancer risk

Kathryn Terry et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)

Review Oncology

Molecular mechanisms of resistance and toxicity associated with platinating agents

Cara A. Rabik et al.

CANCER TREATMENT REVIEWS (2007)

Article Biochemistry & Molecular Biology

MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation

Jer-Yen Yang et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Review Oncology

The p53-Mdm2 module and the ubiquitin system

D Michael et al.

SEMINARS IN CANCER BIOLOGY (2003)

Review Biochemistry & Molecular Biology

p53: Death star

KH Vousden